What's so nice about it BB? It's the same rhetoric
that has been posted here ad naseum, and has been available through the (CDSR) Cochrane Database of Systematic Reviews, and published in PUB MED. XKEM has stated since 2003 that they've been preparing the IND (Investigational New Drug application) for the FDA, but to date, nada! Also, it is well known that PhaseIII trials in Nigeria are not completed (FWIW), despite organizations such as NIPRD (the ahem, owners of this cocktail) attesting that they are complete, utter nonsense.
A simple review of the literature will tell you that Nicosan falls short even in PhaseII Nigerian trials, and that nobody with an ounce of integrity would ever submit Nicosan as an effective treatment, or experiment on a real person, ergo Nicosan's failure to meet the wild-eyed finacial windfall that the company and investors had hoped for :)
Elementary!
Dick_Nixon, nice find! bottom right of page 241 into 242, very interesting!! Thanks for sharing.
